DEXTRAMER - Trademark Details
Status: 706 - A Section 71 declaration has been accepted
Serial Number
79081953
Registration Number
4040266
Word Mark
DEXTRAMER
Status
706 - A Section 71 declaration has been accepted
Status Date
2017-06-09
Filing Date
2009-12-28
Registration Number
4040266
Registration Date
2011-10-18
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2011-08-02
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
ORTIGA PALMER, RAMONA
Statements
Goods and Services
Preparations for pharmaceutical purposes, pharmaceutical preparations for medical purposes, and chemical-pharmaceutical preparations, namely vaccines and for treating infections caused by CMV, LCMV, EBV, HIV, HPV, BK polyomavirus, HTLV, Hepatitis B, Hepatitis C, TB, Graft versus Host Disease, Diabetes, JC Polyomavirus, HHV-3 (Human Herpes Virus), Influenza, Murine Herpes, Malaria, Murine Polyomavirus, RSV, HPV, Herpes Simplex Virus II, Sendai Virus, M Bovis, Vesicular Stromatitis Virus, Vaccinia Virus, Toxoplasmosis, Trypanosomacruzi, SIV, and vaccines and treatments for cancer, diabetes, arthritis, schlerosis, Achlorhydra Autoimmune Active Chronic Hepatitis, Acute Disseminated Encephalomyelitis, Acute hemorrhagic leukoencephalitis, Addison's Disease, Agammaglobulinemia, Alopecia areata, Amyotrophic Lateral Sclerosis, Ankylosing Spondylitis, Anti-GBM/TBM Nephritis, Antiphospholipid syndrome, Antisynthetase syndrome, Arthritis, Atopic allergy, Atopic Dermatitis, Autoimmune Aplastic Anemia, Autoimmune cardiomyopathy, Autoimmune hemolytic anemia, Autoimmune hepatitis, Autoimmune inner ear disease, Autoimmune lymphoproliferative syndrome, Autoimmune peripheral neuropathy, Autoimmune pancreatitis, Autoimmune polyendocrine syndrome Types I, II, and III, Autoimmune progesterone dermatitis, Autoimmune thrombocytopenic purpura, Autoimmune uveitis, Balo disease/Balo concentric sclerosis, Bechets Syndrome, Berger's disease, Bickerstaff's encephalitis, Blau syndrome, Bullous Pemphigoid, Castleman's disease, Chagas disease, Chronic Fatigue Immune Dysfunction Syndrome, Chronic antiflammatory demyelinating polyneuropathy, Chronic recurrent multifocal ostomyelitis, Chronic lyme disease, Chronic obstructive pulmonary disease, Churg-Strauss syndrome, CicatricialPemphigoid, Coeliac disease, Cogan syndrome, old agglutinin disease, Complement component 2 deficiency, Cranial arteritis, CREST syndrome, Crohns Disease, Cushing's Syndrome, Cutaneous leukocytoclasticangiitis, Dego's disease, Dercum's disease, Dermatitis herpetiformis, Dermatomyositis, Diabetes mellitus type 1, Diffuse cutaneous systemic sclerosis, Dressler's syndrome, Discoid lupus erythematosus, Eczema, Endometriosis, Enthesitis-related arthritis, Eosinophilic fasciitis, Epidermolysisbullosaacquisita, Erythema nodosum, Essential mixed cryoglobulinemia, Evan's syndrome, Fibrodysplasiaossificans progressive, Fibromyalgia, Fibromyositis, Fibrosingaveolitis, Gastritis, Gastrointestinal pemphigoid, Giant cell arteritis, Glomerulonephritis, Goodpasture's syndrome, Graves' disease, Guillain-Barré syndrome (GBS), Hashimoto's encephalitis, Hashimoto's thyroiditis, Haemolyticanemia, Henoch-Schonleinpurpura, Herpes gestationis, Hidradenitissuppurativa, Hughes syndrome, Hypogammaglobulinemia, Idiopathic Inflammatory Demyelinating Diseases, Idiopathic pulmonary fibrosis, Idiopathic thrombocytopenic purpura, IgA nephropathy (Berger's disease), Inclusion body myositis, Inflammatory demyelinating , olyneuopathy, Interstitial cystitis, Irritable Bowel Syndrome (IBS), Juvenile idiopathic arthritis, Juvenile heumatoid arthritis, Kawasaki's Disease, Lambert-Eaton myasthenic syndrome, Leukocytoclasticvasculitis, Lichen planus, Lichen sclerosus, Linear IgA disease (LAD), Lou Gehrig's Disease (Amyotrophic lateral sclerosis), Lupoid hepatitis, Lupus erythematosus, Majeed syndrome, Ménière's disease, Microscopic, polyangiitis, Miller-Fisher syndrome, Mixed Connective Tissue Disease, Morphea, Mucha-Habermann disease, Muckle-Wells syndrome, Multiple Myeloma, Multiple Sclerosis, Myasthenia gravis, Myositis, Narcolepsy, Neuromyelitisoptica(Devic's Disease), Neuromyotonia, Occularcicatricialpemphigoid, Opsoclonus myoclonus syndrome, Ord's thyroiditis, Palindromic rheumatism, PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus), Paraneoplastic cerebellar degeneration, Paroxysmal nocturnal hemoglobinuria (PNH), Parry Romberg syndrome, Parsonnage-Turner syndrome, Pars planitis, Pemphigus, Pemphigus vulgaris, Pernicious anaemia, Perivenous encephalomyelitis, POEMS syndrome, Polyarteritisnodosa, Polymyalgia rheumatic, Polymyositis, Primary biliary cirrhosis, Primary sclerosing cholangitis, Progressive inflammatory neuropathy, Psoriasis, Psoriatic Arthritis,Pyodermagangrenosum, Pure red cell aplasia, Rasmussen's encephalitis, Raynaud phenomenon, Relapsing polychondritis, Reiter's syndrome, Restless leg syndrome, Retroperitoneal fibrosis, Rheumatoid arthritis, Rheumatoid fever, Sarcoidosis, Schizophrenia, Schmidt syndrome, Schnitzler syndrome, Scleritis, Scleroderma, Sjögren's syndrome, Spondyloarthropathy, Sticky blood syndrome, Still's Disease, Stiff person syndrome, Subacute bacterial endocarditis (SBE), Susac's syndrome, Sweet syndrome, Sydenham Chorea, Sympathetic ophthalmia, Takayasu's arteritis, Temporal arteritis (giant cell arteritis), Tolosa-Hunt syndrome, Transverse Myelitis, Ulcerative Colitis, Undifferentiated connective tissue disease, Undifferentiated spondyloarthropathy, Vasculitis, Vitiligo, Wegener's granulomatosis, Wilson's syndrome, Wiskott-Aldrich syndrome, T-cell lymphoma, and T-cell infiltration of solid tumors and tissue; diagnostic preparations for medical purposes, reagents for medical and veterinary purposes and for research, preparations for analysis for medical and research purposes, hereunder for each of the abovementioned preparations for development and analysis of vaccines and treatments targeting infections by CMV, LCMV, EBV, HIV, HPV, BK polyomavirus, HTLV, Hepatitis B, Hepatitis C, TB, Graft versus Host Disease, Diabetes, JC Polyomavirus, HHV-3 (Human Herpes Virus), Influenza, Murine Herpes, Malaria, Murine Polyomavirus, RSV, HPV, Herpes Simplex Virus II, Sendai Virus, M Bovis, Vesicular Stromatitis Virus, Vaccinia Virus, Toxoplasmosis, Trypanosomacruzi, SIV, and vaccines and treatments for cancer, diabetes, arthritis, schlerosis, Achlorhydra Autoimmune Active Chronic Hepatitis, Acute Disseminated Encephalomyelitis, Acute hemorrhagic leukoencephalitis, Addison's Disease, Agammaglobulinemia, Alopecia areata, Amyotrophic Lateral Sclerosis, Ankylosing Spondylitis, Anti-GBM/TBM Nephritis, Antiphospholipid syndrome, Antisynthetase syndrome, Arthritis, Atopic allergy, Atopic Dermatitis, Autoimmune Aplastic Anemia, Autoimmune cardiomyopathy, Autoimmune hemolytic anemia, Autoimmune hepatitis, Autoimmune inner ear disease, Autoimmune lymphoproliferative syndrome, Autoimmune peripheral neuropathy, Autoimmune pancreatitis, Autoimmune polyendocrine syndrome Types I, II, and III, Autoimmune progesterone dermatitis, Autoimmune thrombocytopenic purpura, Autoimmune uveitis, Balo disease/Balo concentric sclerosis, Bechets Syndrome, Berger's disease, Bickerstaff's encephalitis, Blau syndrome, Bullous Pemphigoid, Castleman's disease, Chagas disease, Chronic Fatigue Immune Dysfunction Syndrome, Chronic inflammatory demyelinating polyneuropathy, Chronic recurrent multifocal ostomyelitis, Chronic lyme disease, Chronic obstructive pulmonary disease, Churg-Strauss syndrome, CicatricialPemphigoid, Coeliac disease, Cogan syndrome, old agglutinin disease, Complement component 2 deficiency, Cranial arteritis, CREST syndrome, Crohns Disease, Cushing's Syndrome, Cutaneous leukocytoclasticangiitis, Dego's disease, Dercum's disease, Dermatitis herpetiformis, Dermatomyositis, Diabetes mellitus type 1, Diffuse cutaneous systemic sclerosis, Dressler's syndrome, Discoid lupus erythematosus, Eczema, Endometriosis, Enthesitis-related arthritis, Eosinophilic fasciitis, Epidermolysisbullosaacquisita, Erythema nodosum, Essential mixed cryoglobulinemia, Evan's syndrome, Fibrodysplasiaossificans progressive, Fibromyalgia, Fibromyositis, Fibrosingaveolitis, Gastritis, Gastrointestinal pemphigoid, Giant cell arteritis, Glomerulonephritis, Goodpasture's syndrome, Graves' disease, Guillain-Barré syndrome (GBS), Hashimoto's encephalitis, Hashimoto's thyroiditis, Haemolytic anemia,Henoch-Schonleinpurpura, Herpes gestationis, Hidradenitissuppurativa, Hughes syndrome, Hypogammaglobulinemia, Idiopathic Inflammatory Demyelinating Diseases, Idiopathic pulmonary fibrosis, Idiopathic thrombocytopenic purpura, IgA nephropathy (Berger's disease), Inclusion body myositis, Inflammatory demyelinating, olyneuopathy, Interstitial cystitis, Irritable Bowel Syndrome (IBS), Juvenile idiopathic arthritis, Juvenile heumatoid arthritis, Kawasaki's Disease, Lambert-Eaton myasthenic syndrome, Leukocytoclasticvasculitis, Lichen planus, Lichen sclerosus, Linear IgA disease (LAD), Lou Gehrig's Disease (Amyotrophiclateral sclerosis), Lupoid hepatitis, Lupus erythematosus, Majeed syndrome, Ménière's disease, Microscopic polyangiitis, Miller-Fisher syndrome, Mixed Connective Tissue Disease, Morphea, Mucha-Habermann disease, Muckle-Wells syndrome, Multiple Myeloma, Multiple Sclerosis, Myasthenia gravis, Myositis, Narcolepsy, Neuromyelitisoptica (Devic's Disease), Neuromyotonia, Occularcicatricialpemphigoid, Opsoclonus myoclonus syndrome, Ord's thyroiditis, Palindromic rheumatism, PANDAS (Pediatric autoimmune Neuropsychiatric Disorders Associated withStreptococcus), Paraneoplastic cerebellar degeneration, Paroxysmal nocturnal hemoglobinuria (PNH), Parry Romberg syndrome, Parsonnage-Turner syndrome, Pars planitis, Pemphigus, Pemphigus vulgaris, Pernicious anaemia, Perivenous encephalomyelitis, POEMS syndrome, Polyarteritisnodosa, Polymyalgia rheumatic, Polymyositis, Primary biliary cirrhosis, Primary sclerosing cholangitis, Progressive inflammatory neuropathy, Psoriasis, Psoriatic Arthritis, Pyodermagangrenosum, Pure red cell aplasia, Rasmussen's encephalitis, Raynaud phenomenon, Relapsingpolychondritis, Reiter's syndrome, Restless leg syndrome, Retroperitoneal fibrosis, Rheumatoid arthritis, Rheumatoid fever, Sarcoidosis, Schizophrenia, Schmidt syndrome, Schnitzler syndrome, Scleritis, Scleroderma, Sjögren's syndrome, Spondyloarthropathy, Sticky blood syndrome, Still's Disease, Stiff person syndrome, Subacute bacterial endocarditis (SBE), Susac's syndrome, Sweet syndrome, Sydenham Chorea, Sympathetic ophthalmia, Takayasu's arteritis, Temporal arteritis (giant cell arteritis), Tolosa-Hunt syndrome, Transverse Myelitis, Ulcerative Colitis, Undifferentiated connective tissue disease, Undifferentiated spondyloarthropathy, Vasculitis, Vitiligo, Wegener's granulomatosis, Wilson's syndrome, Wiskott-Aldrich syndrome, T-cell lymphoma, and T-cell infiltration of solid tumors and tissue, and for use in connection with toxicological studies, transplantation, immune monitoring, and vaccines and T-cell monitoring
Goods and Services
Scientific and technological services and research and design relating thereto in the field of vaccines, immunotherapy, and the measurement of immune responses; industrial analysis and research services in the field of vaccines, immunotherapy, and the measurement of immune responses; basic research and clinical research in the field of medicine and vaccine development
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2010-05-22
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2010-05-22
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (limited company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Julie A. Greenberg
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1036987
International Registration Date
2009-12-28
International Publication Date
2010-05-27
International Renewal Date
2029-12-28
Auto Protection Date
2012-01-29
International Status
001 - Request for extension of protection established
International Status Date
2010-05-20
Priority Claimed In
True
Priority Claimed Date
2009-10-26
First Refusal In
True
Trademark Events
Event Date | Event Description |
2010-05-20 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2010-05-22 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2010-05-22 | ASSIGNED TO EXAMINER |
2010-05-26 | APPLICATION FILING RECEIPT MAILED |
2010-05-29 | NON-FINAL ACTION WRITTEN |
2010-05-30 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2010-06-01 | REFUSAL PROCESSED BY MPU |
2010-06-01 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2010-07-02 | REFUSAL PROCESSED BY IB |
2010-07-30 | CORRECTION TRANSACTION RECEIVED FROM IB |
2010-08-05 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
2010-12-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2010-12-28 | ASSIGNED TO LIE |
2010-12-28 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2010-12-28 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2010-12-28 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2011-01-23 | NON-FINAL ACTION WRITTEN |
2011-01-23 | NON-FINAL ACTION E-MAILED |
2011-01-23 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2011-05-25 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2011-05-25 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2011-05-25 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2011-05-25 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2011-06-08 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2011-06-08 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2011-06-21 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2011-06-29 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2011-07-13 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2011-07-13 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2011-08-02 | PUBLISHED FOR OPPOSITION |
2011-08-02 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2011-10-02 | NOTIFICATION PROCESSED BY IB |
2011-10-18 | REGISTERED-PRINCIPAL REGISTER |
2012-01-18 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2012-05-30 | FINAL DISPOSITION PROCESSED |
2012-05-30 | FINAL DISPOSITION NOTICE SENT TO IB |
2012-06-15 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2016-10-18 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
2016-12-22 | NEW REPRESENTATIVE AT IB RECEIVED |
2017-02-15 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2017-02-15 | TEAS SECTION 71 RECEIVED |
2017-03-02 | NEW REPRESENTATIVE AT IB RECEIVED |
2017-06-08 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2017-06-09 | REGISTERED-SEC.71 ACCEPTED |
2017-06-09 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
2017-08-31 | NEW REPRESENTATIVE AT IB RECEIVED |
2019-01-25 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2019-01-25 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-01-16 | INTERNATIONAL REGISTRATION RENEWED |
2020-10-18 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
2021-07-12 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2021-07-12 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-07-12 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-07-12 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-07-12 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2021-09-28 | TEAS SECTION 71 RECEIVED |
2022-01-21 | CHANGE OF NAME/ADDRESS REC'D FROM IB |